blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1091000

EP1091000 - An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.09.2005
Database last updated on 20.09.2024
Most recent event   Tooltip19.03.2010Change - representativepublished on 21.04.2010  [2010/16]
Applicant(s)For all designated states
Hobom, Gerd, Prof. Dr. Dr.
Arndtstrasse 14
35392 Giessen / DE
[2001/15]
Inventor(s)01 / Hobom, Gerd, Prof.Dr.Dr.
Arndtstrasse 14
35392 Giessen / DE
02 / Neumann, Gabriele
Hermann-Löns-Strasse 7
63447 Maintal / DE
03 / Menke, Annette
Ockershäuser Alle 7
35037 Marburg / DE
 [2001/15]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2010/15]von Kreisler Selting Werner
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2001/15]Helbing, Jörg, Dr. Dipl.-Chem., et al
Patentanwälte von Kreisler-Selting-Werner, Postfach 10 22 41
50462 Köln / DE
Application number, filing date00124417.718.09.1995
[2001/15]
Priority number, dateEP1994011550530.09.1994         Original published format: EP 94115505
[2001/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1091000
Date:11.04.2001
Language:EN
[2001/15]
Search report(s)(Supplementary) European search report - dispatched on:EP21.02.2001
ClassificationIPC:C12N15/86, C12N7/00, C12N15/62, A61K39/145, A61K35/76
[2001/15]
CPC:
C12N15/86 (EP,US); C12N7/00 (EP,US); A61K2039/5256 (EP,US);
C12N2760/16143 (EP,US); C12N2760/16161 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/15]
TitleGerman:Abgeschwächtes Impf- und gentransfervirus, Verfahren zur dessen Herstellung und Arzneimittel die es enthalten[2001/15]
English:An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus[2001/15]
French:Virus atténué pour la vaccination et le transfert de gènes, méthode pour sa fabrication et compositions pharmaceutiques le contenant[2001/15]
Examination procedure06.10.2001Examination requested  [2001/49]
01.04.2005Application deemed to be withdrawn, date of legal effect  [2005/42]
19.05.2005Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2005/42]
Parent application(s)   TooltipEP95933386.5  / EP0783586
Fees paidRenewal fee
08.11.2000Renewal fee patent year 03
08.11.2000Renewal fee patent year 04
08.11.2000Renewal fee patent year 05
08.11.2000Renewal fee patent year 06
26.09.2001Renewal fee patent year 07
20.09.2002Renewal fee patent year 08
26.09.2003Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.09.200410   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO9639179  (AVIRON INC [US]) [E] 1-4* example 2 *;
 [XY]  - PICCONE, M. ET AL., "MUTATIONAL ANALYSIS OF THE INFLUENZA VIRUS VRNA PROMOTER.", VIRUS RES 28 (2). 1993. 99-112, XP000619019 [X] 1-5 * page 101, 'Construction of plasmids' * * figures 3,5 * [Y] 1-8

DOI:   http://dx.doi.org/10.1016/0168-1702(93)90129-B
 [DY]  - ZOBEL A ET AL, "RNA polymerase I catalysed transcription of insert viral cDNA", NUCLEIC ACIDS RESEARCH, (1993), vol. 21, no. 16, ISSN 0305-1048, pages 3607 - 3614, XP002110227 [DY] 1-4 * the whole document *
 [Y]  - LI, S. ET AL., "Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, vol. 67, no. 11, pages 6659 - 6666, XP000619016 [Y] 5-8 * the whole document *
 [A]  - LUYTJES, W. ET AL., "Amplification, expression, and packaging of a foreign gene by influenza virus", CELL, (19891222), vol. 59, no. 6, pages 1107 - 1113, XP000083570 [A] 5-8 * the whole document *

DOI:   http://dx.doi.org/10.1016/0092-8674(89)90766-6
 [DA]  - NEUMANN G ET AL, "RNA POLYMERASE I-MEDIATED EXPRESSION OF INFLUENZA VIRAL RNA MOLECULES", VIROLOGY, (1994), vol. 202, no. 1, ISSN 0042-6822, pages 477 - 479, XP000952667 [DA] 1-4 * the whole document *

DOI:   http://dx.doi.org/10.1006/viro.1994.1365
 [DA]  - FODOR, E. ET AL., "The influenza virus panhandle is involved in the initiation of transcription", JOURNAL OF VIROLOGY, vol. 68, no. 6, pages 4092 - 4096, XP000608116
 [DA]  - LI, X. ET AL., "MUTATIONAL ANALYSIS OF THE PROMOTER REQUIRED FOR INFLUENZA VIRUS VIRION RNA SYNTHESIS.", J VIROL 66 (7). 1992. 4331-4338, XP000619017
 [PX]  - NEUMANN, G. ET AL., "Mutational analysis of influenza virus promoter elements in vivo.", JOURNAL OF GENERAL VIROLOGY 76 (7). 1709-1717, (1995), XP002140118 [PX] 1-5 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.